No Data
No Data
Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV
Neurogene Says Participant In Ongoing Phase 1/2 Clinical Trial For Rett Syndrome Who Was Dosed On November 5 With 3E15 Vg Of NGN-401 And Was Previously In Critical Condition, Has Died
BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.
BriaCell Announces First Patient Dosed With Bria-OTS in Metastatic Breast Cancer Study
Express News | Briacell Announces First Patient Dosed With Bria-Ots™ in Metastatic Breast Cancer Study
UniQure Has Dosed The First Patient In GenTLE Phase 1/2a Trial Of AMT-260 For Refractory Mesial Temporal Lobe Epilepsy
No Data
No Data